NCT04413331 Prospective Longitudinal Cohort Study of Vasculitis Patients
| NCT ID | NCT04413331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Vasculitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 670 participants |
| Start Date | 2020-07-02 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 670 participants in total. It began in 2020-07-02 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
VASCO is a prospective observational cohort study which aim to describe the presentation, comorbidities, management, outcomes and damage of vasculitis patients, from the analysis of the clinical, biological and immunological data.
Eligibility Criteria
Inclusion Criteria: * Adult patients (age over 18 years), * Patients with vasculitis, as defined in the Chapel Hill International Nomenclature as revised in 2012, * Patients included at an active phase of the disease, either the initial flare or a relapse, * Patients who have been informed and have signed the consent * Pregnant and breastfeeding women may be included in the study, * Affiliated to a social security system (beneficiary or entitled person). Exclusion Criteria: * Refusal of consent or inability to obtain consent, * A patient who is insane or not entitled, for psychiatric reasons or intellectual impairment, to receive information about the protocol and to give informed consent, * Patient under guardianship / curators * Patient on state medical assistance (AME) * Hemoglobin less than 7 g/dl at the time of sampling, * Hemoglobin level less than 9 g/dl at the time of sampling if the patient has respiratory or cardiovascular disease, * Patient weighs less than 18 kg. * Parallel participation in an interventional protocol is permitted.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04413331 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Vasculitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04413331 currently recruiting?
Yes, NCT04413331 is actively recruiting participants. Contact the research team at benjamin.terrier@aphp.fr for enrollment information.
Where is the NCT04413331 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT04413331 clinical trial?
NCT04413331 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 670 participants.